User login
- /content/polatuzumab-plus-br-improves-efficacy-dlbcl
- /hematology-oncology/article/184915/lymphoma-plasma-cell-disorders/polatuzumab-plus-br-improves
- /hematologytimes/article/184915/lymphoma-plasma-cell-disorders/polatuzumab-plus-br-improves-efficacy
- /b-cell-lymphoma-icymi/article/184915/lymphoma-plasma-cell-disorders/polatuzumab-plus-br-improves